Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2703-2709
Published online before print September 21, 2006, doi: 10.1161/01.ATV.0000246774.02426.71
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/12/2703    most recent
01.ATV.0000246774.02426.71v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parks, B. W.
Right arrow Articles by Kabarowski, J. H.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parks, B. W.
Right arrow Articles by Kabarowski, J. H.S.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2703.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Loss of the Lysophosphatidylcholine Effector, G2A, Ameliorates Aortic Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice

Brian W. Parks; Aldons J. Lusis; Janusz H.S. Kabarowski

From the Department of Microbiology (B.W.P., J.H.S.K.), University of Alabama at Birmingham, Ala; and the Department of Medicine (A.J.L.), University of California, Los Angeles, Calif.

Correspondence to Dr Janusz H. S. Kabarowski, Department of Microbiology, University of Alabama at Birmingham, BBRB 334, 19th St S, Birmingham, AL 35294-2170. E-mail janusz{at}uab.edu

Objective— Lysophosphatidylcholine is a major product of low-density lipoprotein (LDL) oxidation and secretory phospholipase A2-mediated lipid hydrolysis within atherosclerotic lesions. The G2A receptor mediates chemotaxis of cultured macrophages and T cells to lysophosphatidylcholine, supporting a pro-atherogenic role for this receptor in vivo. We investigated the ability of G2A to modulate atherosclerosis in mice.

Methods and Results— We measured atherosclerosis in G2A+/+ and G2A–/– LDL receptor knockout (LDLR–/–) mice. Consistent with a previous study, early lesion size at the aortic sinus was unaffected by G2A deficiency. However, G2A deficiency attenuated lesion progression at this site (42% to 44% reduction in average lesion area) and led to robust suppression of atherosclerosis throughout the aorta after short and extended periods of diet intervention (reduction in aortic lesion coverage: 62% to 73% at 9 weeks, 75% to 84% at 20 weeks). In G2A–/–LDLR–/– mice, intimal macrophage accumulation at lesion-prone sites of the aorta was significantly reduced in the absence of any detectable effect on T cell recruitment. Examination of lipoprotein profiles revealed elevated levels of circulating high-density lipoprotein (HDL) cholesterol in G2A–/–LDLR–/– mice compared with their G2A+/+LDLR–/– counterparts after extended periods of diet intervention (54% increase in mean HDL cholesterol concentration).

Conclusion— G2A provides a pro-atherogenic stimulus in vivo consistent with its chemotactic action but to which a pleiotropy of effects, including modulation of lipoprotein metabolism, may also contribute.

The G2A receptor mediates chemotactic and apoptotic effects of lysophosphatidylcholine in vitro. Loss of G2A suppressed aortic atherosclerosis, reduced macrophage accumulation at lesion-prone sites of the aorta, and elevated circulating HDL cholesterol levels in LDLR knockout mice. A pleiotropy of effects may contribute to the pro-atherogenic action of G2A.


Key Words: atherosclerosis • chemotaxis • G2A • lysophosphatidylcholine • macrophages




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
X. Ye
Lysophospholipid signaling in the function and pathology of the reproductive system
Hum. Reprod. Update, September 1, 2008; 14(5): 519 - 536.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. J. Guzik, N. E. Hoch, K. A. Brown, L. A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D. G. Harrison
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction
J. Exp. Med., October 1, 2007; 204(10): 2449 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Irani
G Protein-Coupled Receptor G2A: Friend or Foe of the Vasculature?
Circ. Res., March 2, 2007; 100(4): 450 - 451.
[Full Text] [PDF]